Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

127
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
127
Narcolepsy01:07

Narcolepsy

84
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
84
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

405
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
405
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

1.2K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.2K
Stages of Sleep01:22

Stages of Sleep

160
Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
160
Neural Regulation01:37

Neural Regulation

39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Prodromal Synucleinopathy Rating Scale: An Assessment in Patients With REM Sleep Behavior Disorder.

Neurology·2026
Same author

Overnight sleep features and next-morning brain metabolism in older adults.

Sleep medicine·2026
Same author

Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio.

JAMA neurology·2026
Same author

Tau PET overlap index correlation with neuropathological findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

The North American Prodromal Synucleinopathy study: protocol for a multi-site, longitudinal, observational study of idiopathic/isolated rapid eye movement sleep behavior disorder.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

Establishing an Alzheimer Disease Therapeutics Clinic: Experience From a Year of Evaluations.

Mayo Clinic proceedings·2026
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Related Experiment Video

Updated: May 21, 2025

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.2K

Sleep and Prodromal Synucleinopathies.

Johnson D Pounders1, Stuart J McCarter1,2

  • 1Mayo Clinic Department of Neurology, Division of Behavioral Neurology Rochester, Minnesota.

Seminars in Neurology
|March 17, 2025
PubMed
Summary
This summary is machine-generated.

Sleep dysfunction, particularly isolated REM sleep behavior disorder (iRBD), is a key early sign of alpha-synucleinopathies. iRBD indicates a high risk for developing symptomatic neurodegenerative disease soon.

More Related Videos

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

364
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.5K

Related Experiment Videos

Last Updated: May 21, 2025

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.2K
Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

364
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.5K

Area of Science:

  • Neurology
  • Sleep Medicine
  • Neurodegenerative Diseases

Background:

  • Alpha-synucleinopathies are progressive neurodegenerative disorders.
  • These conditions feature a lengthy prodromal phase marked by sleep disturbances.
  • The
  • body-first
  • disease progression model highlights the significance of sleep disorders.

Purpose of the Study:

  • To examine the role of sleep dysfunction in the prodromal stage of alpha-synucleinopathies.
  • To assess the prognostic value of specific sleep disorders, especially isolated REM sleep behavior disorder (iRBD).
  • To investigate the association between sleep disorders and the
  • body-first
  • Lewy body disease progression.

Main Methods:

  • Review of current literature on sleep disorders in alpha-synucleinopathies.
  • Analysis of the diagnostic and prognostic significance of isolated REM sleep behavior disorder (iRBD).
  • Exploration of other sleep disturbances like hypersomnia and circadian rhythm dysfunction.

Main Results:

  • Isolated REM sleep behavior disorder (iRBD) is a prominent prodromal marker for alpha-synucleinopathies.
  • Patients with iRBD exhibit abnormal alpha-synuclein even before cognitive or motor symptoms appear.
  • iRBD is associated with an increased risk of developing symptomatic synucleinopathy in the near future.
  • Other sleep disorders like hypersomnia and circadian dysfunction are also observed but have less understood prognostic value.

Conclusions:

  • Sleep disorders, particularly iRBD, are crucial indicators of the prodromal phase of alpha-synucleinopathies.
  • iRBD signifies an elevated risk for imminent symptomatic disease development.
  • Further research is needed to fully understand the prognostic implications of various sleep disturbances, including isolated REM sleep without atonia.